Institutional investors purchased a net $35.0 million shares of TEVA during the quarter ended December 2016 and now own 60.37% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Generic industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 23.5 Million shares of Teva Pharmaceutical
BLACKROCK FUND ADVISORS Bought 19.8 Million shares of Teva Pharmaceutical
HIGHFIELDS CAPITAL MANAGEMENT LP Bought 8.7 Million shares of Teva Pharmaceutical